Form 4: Laboratory Corp of America Holdings Executive Sells Shares Under 10b5-1 Plan

Mark S. Schroeder, EVP, Pres Diagnostics & COO of Laboratory Corp of America Holdings, sold 6,477 shares of common stock at a price of $217.29 per share on April 1, 2024, according to a Form 4 filing with the SEC.

Summary

• Mark S. Schroeder, an executive at Laboratory Corp of America Holdings, sold 6,477 shares of common stock on April 1, 2024.
• The sale was executed at a price of $217.29 per share.
• The transaction was conducted under a pre-arranged trading plan in accordance with Rule 10b5-1.
• Following the transaction, Schroeder directly owns 5,036.1426 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged 10b5-1 trading plan, which suggests it was planned in advance and may not reflect a change in the executive's outlook on the company.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under 10b5-1 plans are often pre-scheduled and may not necessarily reflect a change in management's outlook.

Key Dates